{
    "nct_id": "NCT02948751",
    "official_title": "Pilot Study Evaluating the Utility of OncoCEE (Cell Enrichment and Extraction) Technology, a Novel Immunocytochemical Microfluidic Device, in the Diagnosis of Leptomeningeal Metastasis (LM) From Breast Cancer Through Identification of Circulating Tumor Cells (CTCs) in Cerebrospinal Fluid (CSF)",
    "inclusion_criteria": "* Adult (18 years or older) patients, with invasive breast cancer, of all racial and ethnic origins\n* Undergoing lumbar puncture for clinical or radiographic suspicion of leptomeningeal metastasis\n* Provide study-specific informed consent\n* Patients with unequivocal or suspicious MRI findings.\n* Of those with a definitive diagnosis of LM (i.e. positive CSF cytology), 10 evaluable patients will be accrued.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior CSF fluid which identified malignant cells after 10 evaluable patients with positive CSF are accrued.",
    "miscellaneous_criteria": ""
}